AMT Theater was created out of covid as an affordable theater alternative for those living in Hell's Kitchen and the heart of ...

10 min read | The FDA wants more data before approving AMT-130 for Huntington’s disease in the U.S. On March 2026, uniQure ...

American Tower (AMT) delivered FFO and revenue surprises of +3.63% and +2.29%, respectively, for the quarter ended December ...

While the FDA appears to be adamant that uniQure conduct a sham surgery–controlled Phase 3 trial before AMT-130 can be ...

Insights from a financial advisor ...

While requests by government officials for anonymity when speaking to the media are nothing new, the practice attracts more scrutiny when the Department for Health and Human Services has pledged a ...

Qure’s modelled fair value has been reduced from about US$53.54 to about US$28.67 per share, a cut of close to 50% in the latest update. This reset aligns with Street research, where some firms have ...

BHPian Blooming Flower recently shared this with other enthusiasts:Quick Ownership UpdateOn regular days, 80% of the drive is ...

NRK municipal CEF downgraded to hold: discount to NAV narrowed, and 8% yield relies on return of capital, risking cuts.

AMT-130 Huntington’s gene therapy data, FDA Phase III sham-trial push, cash runway, and 2026 catalysts—read now.

First Drive Review of Tata Punch facelift with 120PS Turbo petrol & iCNG AMT. Detailed performance, mileage, off-road ability ...

American Tower (AMT) reported $2.74 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 7.5%. EPS of $2.63 for the same period compares to $2.62 a year ...